Ramesh Hariharan
Corporate Officer/Principal bij NATERA, INC.
Profiel
Ramesh Hariharan is currently working as the General Manager-Women's Health at Natera, Inc. Previously, he worked as the Vice President-Marketing at Biotheranostics, Inc. from 2014 to 2016.
Dr. Hariharan holds a doctorate degree from Princeton University, an undergraduate degree from the Indian Institute of Technology Bombay, and an MBA from Mit Solan School of Management.
Actieve functies van Ramesh Hariharan
| Bedrijven | Functie | Begin |
|---|---|---|
| NATERA, INC. | Corporate Officer/Principal | - |
Eerdere bekende functies van Ramesh Hariharan
| Bedrijven | Functie | Einde |
|---|---|---|
Biotheranostics, Inc.
 Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Verkoop & Marketing | 01-04-2016 |
Opleiding van Ramesh Hariharan
| Princeton University | Doctorate Degree |
| Indian Institute of Technology Bombay | Undergraduate Degree |
| Mit Solan School of Management | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NATERA, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Biotheranostics, Inc.
Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Health Services |
